CEL-SCI Corp

NYSE MKT:CVM USA Biotechnology
Market Cap
$30.45 Million
Market Cap Rank
#24166 Global
#8384 in USA
Share Price
$3.60
Change (1 day)
+1.98%
52-Week Range
$0.19 - $13.04
All Time High
$27.64
About

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation S… Read more

CEL-SCI Corp (CVM) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: -0.361x

Based on the latest financial reports, CEL-SCI Corp (CVM) has a cash flow conversion efficiency ratio of -0.361x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.02 Million) by net assets ($11.14 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

CEL-SCI Corp - Cash Flow Conversion Efficiency Trend (1989–2025)

This chart illustrates how CEL-SCI Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

CEL-SCI Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CEL-SCI Corp ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for CEL-SCI Corp (1989–2025)

The table below shows the annual cash flow conversion efficiency of CEL-SCI Corp from 1989 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 $15.96 Million $-17.12 Billion -1072.861x -73284.95%
2024-09-30 $12.87 Million $-18.81 Million -1.462x +15.44%
2023-09-30 $13.21 Million $-22.85 Million -1.729x -204.86%
2022-09-30 $32.16 Million $-18.24 Million -0.567x -70.66%
2021-09-30 $56.53 Million $-18.79 Million -0.332x +57.09%
2020-09-30 $19.73 Million $-15.28 Million -0.774x +75.64%
2019-09-30 $5.13 Million $-16.32 Million -3.179x +99.98%
2018-09-30 $916.00 $-13.39 Million -14617.421x -353771.50%
2017-09-30 $-3.34 Million $-13.79 Million 4.133x -82.88%
2016-09-30 $-956.07K $-23.08 Million 24.143x +429.82%
2015-09-30 $-5.23 Million $-23.83 Million 4.557x +307.56%
2014-09-30 $10.44 Million $-22.93 Million -2.195x -8.57%
2013-09-30 $6.70 Million $-13.55 Million -2.022x -16.58%
2012-09-30 $7.03 Million $-12.19 Million -1.735x +30.18%
2011-09-30 $9.08 Million $-22.56 Million -2.484x -440.47%
2010-09-30 $27.85 Million $-12.80 Million -0.460x +37.61%
2009-09-30 $8.84 Million $-6.51 Million -0.737x -0.52%
2008-09-30 $10.84 Million $-7.94 Million -0.733x -119.87%
2007-09-30 $14.67 Million $-4.89 Million -0.333x -103.58%
2006-09-30 $-930.60K $-8.68 Million 9.323x +739.38%
2005-09-30 $2.11 Million $-3.07 Million -1.458x -75.65%
2004-09-30 $5.30 Million $-4.40 Million -0.830x +59.94%
2003-09-30 $1.23 Million $-2.54 Million -2.072x +47.99%
2002-09-30 $1.06 Million $-4.23 Million -3.984x -85.67%
2001-09-30 $4.00 Million $-8.59 Million -2.146x -226.12%
2000-09-30 $12.96 Million $-8.53 Million -0.658x +25.84%
1999-09-30 $7.10 Million $-6.30 Million -0.887x -110.55%
1998-09-30 $14.00 Million $-5.90 Million -0.421x +58.57%
1997-09-30 $5.80 Million $-5.90 Million -1.017x -122.64%
1996-09-30 $11.60 Million $-5.30 Million -0.457x +37.34%
1995-09-30 $4.80 Million $-3.50 Million -0.729x -22.14%
1994-09-30 $6.70 Million $-4.00 Million -0.597x -195.79%
1993-09-30 $10.90 Million $-2.20 Million -0.202x -91.74%
1992-09-30 $13.30 Million $-1.40 Million -0.105x +89.47%
1991-09-30 $900.00K $-900.00K -1.000x --
1990-09-30 $0.00 $-700.00K x --
1989-09-30 $0.00 $-500.00K x --